Skip to main content

Heart Failure News (Page 5)

Related terms: CHF

Strike a Pose: Yoga Helps Heart Failure Patients

TUESDAY, Sept. 26, 2023 – Heart failure can make everyday activities and exercise tough to carry out, but yoga might be a beneficial add-on to standard care. A new study from India finds this...

Novel Model Aids Prediction of Survival in Heart Failure With Reduced Ejection Fraction

MONDAY, Sept. 25, 2023 – For individuals with heart failure with reduced ejection fraction (HFrEF), a new model facilitates prediction of lifelong overall and heart failure hospitalization-free...

ESC: Catheter Ablation Aids Symptomatic Atrial Fibrillation, End-Stage Heart Failure

WEDNESDAY, Aug. 30, 2023 – For patients with atrial fibrillation and end-stage heart failure, the combination of catheter ablation and guideline-directed medical therapy is associated with a lower...

ESC: Treating Iron Deficiency May Not Aid Heart Failure Patients

TUESDAY, Aug. 29, 2023 – Ferric carboxymaltose does not improve a hierarchical composite outcome of death, heart failure hospitalizations, and exercise function in ambulatory patients with heart...

ESC: Semaglutide Beneficial for HFpEF Patients With Obesity

TUESDAY, Aug. 29, 2023 – For patients with heart failure with preserved ejection fraction and obesity, semaglutide is associated with a larger reduction in symptoms and physical limitations,...

Wegovy May Be Valuable New Option for Heart Failure Patients

FRIDAY, Aug. 25, 2023 – Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs...

AHA News: What Is Shared Decision-Making, and How Can It Help Patients?

MONDAY, Aug. 14, 2023 (American Heart Association News) – Traditionally, many decisions about medical treatment were left up to doctors: They decided, and patients agreed. Today, health care...

AHA News: Mom of 2 Survived Heart Failure During Pregnancy and Became Certified Paramedic

WEDNESDAY, Aug. 2, 2023 (American Heart Association News) – Since she was a child, Yanela Vickers has loved babies and the medical field. She dreamed of going into obstetrics and gynecology....

Increasing Daily Step Counts Tied to Improved Heart Failure Outcomes

FRIDAY, July 28, 2023 – Increasing step counts are significantly associated with improvements in health status among patients with heart failure, according to a study published online July 26 in...

Step Counts Aren't Just for the Healthy: They Also Help Heart Failure Patients

WEDNESDAY, July 26, 2023 – Wearable devices like smartwatches continually track physical activity, urging folks to take more daily steps for their health. Now, a new study suggests this gentle...

Injectafer Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure

BASKING RIDGE, N.J. & SHIRLEY, N.Y.--(BUSINESS WIRE) June 05, 2023 --Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug...

FDA Approves Inpefa (sotagliflozin) for the Treatment of Heart Failure

THE WOODLANDS, Texas, May 26, 2023 (GLOBE NEWSWIRE) – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the U.S. Food and Drug Administration (FDA) has approved Inpefa™ (...

FDA Approves Furoscix (furosemide injection) for the At-Home Treatment of Congestion Due to Fluid Overload in Chronic Heart Failure

Furoscix demonstrated 99.6% bioavailability and produced similar diuresis and natriuresis compared to intravenous furosemide BURLINGTON, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) – scPharmaceuticals...

US FDA Approves Jardiance (empagliflozin) to Treat Adults with Heart Failure Regardless of Left Ventricular Ejection Fraction

RIDGEFIELD, Conn. and INDIANAPOLIS, Feb. 24, 2022 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved Jardiance® (empagliflozin) 10 mg to reduce the risk of cardiovascular death ...

FDA Approves Soaanz (torsemide) for Edema Treatment in Patients with Heart Failure and Renal Disease

VIENNA, VA. (PRWEB) JUNE 21, 2021 Sarfez Pharmaceuticals announced today approval by the U.S. Food and Drug Administration (FDA) of the Virginia-based company’s New Drug Application for Soaanz, a o...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Left Ventricular Dysfunction, Cardiovascular Conditions and Disorders

Related drug support groups

lisinopril, metoprolol, warfarin, Coumadin, spironolactone, triamcinolone, carvedilol, Metoprolol Succinate ER, diltiazem, view more... Lasix, furosemide, bisoprolol, valsartan, Entresto, Farxiga, ramipril, Jardiance, digoxin, prazosin, Diovan, nitroglycerin, Coreg